title: FK 506 used as rescue therapy for human liver allograft recipients.
authors.affiliation: Department of Pathology, Presbyterian University Hospital, University of Pittsburgh, PA 15213.
authors.forename: A J
authors.initials: AJ
authors.lastname: Demetris
authors.forename: J J
authors.initials: JJ
authors.lastname: Fung
authors.forename: S
authors.initials: S
authors.lastname: Todo
authors.forename: J
authors.initials: J
authors.lastname: McCauley
authors.forename: A
authors.initials: A
authors.lastname: Jain
authors.forename: S
authors.initials: S
authors.lastname: Takaya
authors.forename: M
authors.initials: M
authors.lastname: Alessiani
authors.forename: K
authors.initials: K
authors.lastname: Abu-Elmagd
authors.forename: D H
authors.initials: DH
authors.lastname: Van Thiel
authors.forename: T E
authors.initials: TE
authors.lastname: Starzl
mesh_terms: D000208:Acute Disease; D002908:Chronic Disease; D016572:Cyclosporine / Q000627:therapeutic use; D005500:Follow-Up Studies; D006084:Graft Rejection; D006801:Humans; D016031:Liver Transplantation / Q000276:immunology* / Q000473:pathology / Q000502:physiology; D013256:Steroids / Q000627:therapeutic use; D014184:Transplantation, Homologous; D016896:Treatment Outcome
chemical_list: D013256:Steroids; D016572:Cyclosporine